244 related articles for article (PubMed ID: 18952766)
1. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications.
Gulcelik NE; Karakaya J; Gedik A; Usman A; Gurlek A
Eur J Endocrinol; 2009 Jan; 160(1):65-70. PubMed ID: 18952766
[TBL] [Abstract][Full Text] [Related]
2. Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications.
Yang W; Li Y; Tian T; Wang L; Lee P; Hua Q
BMC Endocr Disord; 2017 Oct; 17(1):67. PubMed ID: 29065866
[TBL] [Abstract][Full Text] [Related]
3. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
4. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
[TBL] [Abstract][Full Text] [Related]
5. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
6. Serum Levels of Vaspin and Its Correlation with Nitric Oxide in Type 2 Diabetic Patients with Nephropathy.
Mihanfar A; Rahmati-Yamchi M; Mota A; Abediazar S; Pilehvar-Soltanahmadi Y; Zarghami N
Curr Diabetes Rev; 2018; 14(2):162-167. PubMed ID: 28554309
[TBL] [Abstract][Full Text] [Related]
7. Role of serum vaspin in progression of type 2 diabetes: a 2-year cohort study.
Jian W; Peng W; Xiao S; Li H; Jin J; Qin L; Dong Y; Su Q
PLoS One; 2014; 9(4):e94763. PubMed ID: 24732788
[TBL] [Abstract][Full Text] [Related]
8. Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes.
Ye Y; Hou XH; Pan XP; Lu JX; Jia WP
Chin Med J (Engl); 2009 Nov; 122(21):2530-3. PubMed ID: 19951565
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
10. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
11. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
Yang CY; Su PF; Hung JY; Ou HT; Kuo S
Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
[TBL] [Abstract][Full Text] [Related]
12. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels and placental expression of vaspin in pregnant women with diabetes mellitus.
Huo Y; Liu SX; Song GY; Ren LP; Wang C; Zhang DH
Braz J Med Biol Res; 2015 Mar; 48(3):273-9. PubMed ID: 25608237
[TBL] [Abstract][Full Text] [Related]
14. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
Sözmen EY; Sözmen B; Delen Y; Onat T
Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
[TBL] [Abstract][Full Text] [Related]
15. Serum vaspin levels are positively associated with diabetic retinopathy in patients with type 2 diabetes mellitus.
Yang HW; Huang YG; Gai CL; Chai GR; Lee S
J Diabetes Investig; 2021 Apr; 12(4):566-573. PubMed ID: 32797727
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
[TBL] [Abstract][Full Text] [Related]
17. Serum CA 19-9 Level is Correlated to the Clinical Characteristics and Chronic Complications of Patients Newly Diagnosed with Type 2 Diabetes Mellitus.
Cui L; Lv N; Li B; Tao J; Zheng X; Yan Y; Liu C
Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):581-586. PubMed ID: 31461764
[TBL] [Abstract][Full Text] [Related]
18. Serum ferritin levels in poorly- and well-controlled diabetes mellitus.
Canturk Z; Cetinarslan B; Tarkun I; Canturk NZ
Endocr Res; 2003 Aug; 29(3):299-306. PubMed ID: 14535631
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
Huang JX; Liao YF; Li YM
Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
[TBL] [Abstract][Full Text] [Related]
20. Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population.
Teshigawara S; Wada J; Hida K; Nakatsuka A; Eguchi J; Murakami K; Kanzaki M; Inoue K; Terami T; Katayama A; Iseda I; Matsushita Y; Miyatake N; McDonald JF; Hotta K; Makino H
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1202-7. PubMed ID: 22539588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
